Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

Varian and Medison America sign marketing deal:

This article was originally published in Clinica

  • News

Executive Summary

Varian Oncology Systems and Medison America, together with its Cone/Medison joint venture, are to jointly market products for use in radiation oncology, urology and gynaecology. Products covered include: Varian's VariSource high dose rate brachytherapy system; Medison America's Voluson 530D 3D ultrasound system; and Cone/Medison's Combison 301 ultrasound system. The companies aim to increase co-operation in prostate brachytherapy using 3D ultrasound. They will also focus R&D efforts on new applications of 3D ultrasound technology for cancer and other disorders. Varian is based in Palo Alto, Medison in Pleasanton, California, and Cone Medison is located in Solon, Ohio.

Table

View full table

Topics

Tags:
Medical Device
Latest Headlines

Epitel Gets 510(k) Clearance On Remote EEG Technology

Valuable Health Data Sources For Medtech Industry Come A Step Closer In The EU

Rise In Class I Device Recalls A ‘Grave Concern,’ Says FDA’s Anne Reid

Discreet Gait Freezing Solution Brings Therapy With The Tap Of An Apple Watch

See All
UsernamePublicRestriction

Register

MT081584

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By